Chlorine in PDB 6g91: Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

Enzymatic activity of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2

All present enzymatic activity of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2:
2.7.11.24;

Protein crystallography data

The structure of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 6g91 was solved by M.O'reilly, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.36 / 1.80
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 48.775, 70.721, 60.355, 90.00, 109.34, 90.00
R / Rfree (%) 16.6 / 22

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 (pdb code 6g91). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 6g91:

Chlorine binding site 1 out of 1 in 6g91

Go back to Chlorine Binding Sites List in 6g91
Chlorine binding site 1 out of 1 in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl403

b:29.5
occ:1.00
CL1 A:EQW403 0.0 29.5 1.0
C2 A:EQW403 1.7 25.8 1.0
C3 A:EQW403 2.7 24.8 1.0
C14 A:EQW403 2.7 20.1 1.0
H15 A:EQW403 2.9 24.8 1.0
H26 A:EQW403 2.9 19.4 1.0
OE1 A:GLN105 3.1 22.4 1.0
O A:HOH573 3.3 40.5 1.0
O A:HOH851 3.7 46.3 1.0
CD A:GLN105 3.8 27.9 1.0
CB A:GLN105 3.8 18.7 1.0
O A:HOH705 3.8 36.5 1.0
CD1 A:LEU156 3.9 24.8 1.0
N13 A:EQW403 4.0 25.7 1.0
N4 A:EQW403 4.0 23.2 1.0
CB A:ALA52 4.1 25.8 1.0
O A:HOH957 4.3 32.1 1.0
CG A:GLN105 4.3 18.5 1.0
C5 A:EQW403 4.4 25.9 1.0
O A:ASP106 4.5 24.4 1.0
CG1 A:ILE84 4.5 16.8 1.0
NE2 A:GLN105 4.7 21.9 1.0
CD1 A:ILE84 4.9 22.1 1.0

Reference:

T.D.Heightman, V.Berdini, H.Braithwaite, I.M.Buck, M.Cassidy, J.Castro, A.Courtin, J.E.H.Day, C.East, L.Fazal, B.Graham, C.M.Griffiths-Jones, J.F.Lyons, V.Martins, S.Muench, J.M.Munck, D.Norton, M.O'reilly, N.Palmer, P.Pathuri, M.Reader, D.C.Rees, S.J.Rich, C.Richardson, H.Saini, N.T.Thompson, N.G.Wallis, H.Walton, N.E.Wilsher, A.J.Woolford, M.Cooke, D.Cousin, S.Onions, J.Shannon, J.Watts, C.W.Murray. Fragment-Based Discovery of A Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J. Med. Chem. V. 61 4978 2018.
ISSN: ISSN 1520-4804
PubMed: 29775310
DOI: 10.1021/ACS.JMEDCHEM.8B00421
Page generated: Sat Dec 12 13:01:15 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy